CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke
Dr. Tesha Monteith and Dr. Michael Eller discuss the implications of CGRP therapies in migraine treatment, particularly for patients with vascular risk factors or a history of stroke. Show citation…
Read the full articleYou might also wanna read
Intranasal Zavegepant for the acute treatment of migraine in adults: A review of randomized clinical trials
Migraine is a highly prevalent chronic neurological disorder and one of the leading causes of disability worldwide. Among recent therapeutic
CGRP monoclonal antibody fremanezumab may reduce weather-triggered migraine attacks, study finds
Preventive treatment may blunt the impact of weather-related migraine triggers, in what investigators say is a first for migraine prevention
mdsc.pe·21d ago
CME | This Is Giving Me a Headache: Managing the Headache Patient Without Losing Your Mind
In this re-released episode of CME on the Go, originally published on 12/1/2025, our hosts discuss the complexities of diagnosing and treati
Having a stroke increases risk of having another stroke
Nurse practitioner Stephanie Loveless (photo by Jim Howe) Nurse practitioner Stephanie Loveless (photo by Jim Howe) Nurse practitioner Nurse
Comments
Sign in to join the conversation.
No comments yet. Be the first.